Related Experiment Video
Updated: Feb 13, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Endometrial cancer risk and survival by tumor MMR status
Christina M Nagle1,2, Tracy A O'Mara3, Yen Tan3
1Population Health Department, QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital, Brisbane, Australia.
Objective:
The risk of developing endometrial cancer (EC) and/or survival following a diagnosis of EC might differ by tumor DNA mismatch repair (MMR) status. We assessed the association between tumor MMR status (classified as MMR-proficient, somatic MMR-deficient, germline MMR-deficient) and the risk of developing EC and survival following a diagnosis of EC.
Methods:
We analyzed data from women who participated in the Australian National Endometrial Cancer Study (ANECS) conducted between 2005 and 2007. Risk analyses (698 cases/691 population controls) utilized sociodemographic and lifestyle information obtained from telephone interviews at recruitment. For survival analyses (728 cases), patients' clinical data was abstracted from medical records, and survival data were obtained via linkage with the Australian National Death Index. We used logistic regression analysis to evaluate the associations between tumor MMR status and EC risk, and proportional hazards models to perform survival analyses with adjustment of known prognostic factors.
Results:
Established risk factors for EC did not differ significantly by tumor MMR status. In analyses including all EC subtypes, overall and EC-specific survival did not differ by tumor MMR status. Among women with the most common endometrioid subtype, EC-specific survival was worse for women with somatic MMR-deficient EC compared to women with MMR-proficient EC (hazard ratio [HR]=2.18; 95% confidence interval [CI]=1.19-4.01).
Conclusion:
The risk of EC is not associated with MMR status. Accurate separation of germline from somatic causes of MMR deficiency suggests that patients with endometrioid subtype somatic MMR-deficient tumors have poorer EC-specific survival than those with MMR-proficient tumors, after accounting for other prognostic factors.
Insights
Endometrial cancer (EC) risk is not linked to DNA mismatch repair (MMR) status. However, somatic MMR-deficient endometrioid subtype tumors are associated with worse EC-specific survival compared to MMR-proficient tumors.
Area of Science:
- Gynecologic Oncology
- Cancer Genomics
- Molecular Pathology
Background:
- Tumor DNA mismatch repair (MMR) status may influence endometrial cancer (EC) risk and patient outcomes.
- Understanding the distinct roles of germline and somatic MMR deficiency is crucial for accurate prognostication.
Purpose of the Study:
- To assess the association between tumor MMR status (MMR-proficient, somatic MMR-deficient, germline MMR-deficient) and EC risk.
- To evaluate the impact of tumor MMR status on survival following an EC diagnosis.
Main Methods:
- Analysis of data from the Australian National Endometrial Cancer Study (ANECS) (2005-2007).
- Logistic regression for EC risk analysis (698 cases/691 controls).
- Proportional hazards models for survival analysis (728 cases), linked with the Australian National Death Index.
Main Results:
- No significant differences in established EC risk factors by tumor MMR status.
- Overall and EC-specific survival did not differ across MMR status groups for all EC subtypes.
- Among endometrioid subtype EC, somatic MMR-deficient tumors showed significantly worse EC-specific survival (HR=2.18; 95% CI=1.19-4.01) compared to MMR-proficient tumors.
Conclusions:
- Endometrial cancer risk is not associated with MMR status.
- Distinguishing germline from somatic MMR deficiency is important.
- Patients with somatic MMR-deficient endometrioid EC have poorer survival outcomes than those with MMR-proficient tumors.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Survival Tree
Building a Survival Tree
Constructing a...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Relative Risk
Marcia's Theory of Identity Status

